Yes the market generally and biotech in particular is indeed in a funk but PR is not helping with his failure to meet his own recent guidance (or to update it). It leaves me wondering if the results contain some bad news or something difficult to explain/spin away. Either way it reflects poor governance about which much has already been said.
Yes the market generally and biotech in particular is indeed in...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.050(24.4%) |
Mkt cap ! $85.80M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 26.0¢ | 21.0¢ | $659.4K | 2.794M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 72582 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 53319 | 6 |
View Market Depth
| Last trade - 14.22pm 17/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |